Association between statin use and mortality risks during the acute phase of ischemic stroke in patients admitted to an intensive care unit
Open Access
- 1 March 2020
- journal article
- research article
- Published by FapUNIFESP (SciELO) in Arquivos de Neuro-Psiquiatria
- Vol. 78 (3), 158-162
- https://doi.org/10.1590/0004-282x20190172
Abstract
Dyslipidemia is a risk factor for stroke, and statins are used for secondary prevention during the chronic phase of the disease4.Keywords
This publication has 13 references indexed in Scilit:
- V Diretriz Brasileira de Dislipidemias e Prevenção da AteroscleroseArquivos Brasileiros de Cardiologia, 2013
- Análise da tendência da mortalidade por acidente vascular cerebral no Brasil no século XXIArquivos Brasileiros de Cardiologia, 2012
- High-Dose Lovastatin for Acute Ischemic Stroke: Results of the Phase I Dose Escalation Neuroprotection with Statin Therapy for Acute Recovery Trial (NeuSTART)Cerebrovascular Diseases, 2009
- Epidemiology of Ischemic and Hemorrhagic Stroke: Incidence, Prevalence, Mortality, and Risk FactorsNeurologic Clinics, 2008
- Simvastatin in the acute phase of ischemic stroke: a safety and efficacy pilot trialEuropean Journal of Neurology, 2007
- Statin treatment withdrawal in ischemic strokeNeurology, 2007
- High-Dose Atorvastatin after Stroke or Transient Ischemic AttackThe New England Journal of Medicine, 2006
- Statins induce angiogenesis, neurogenesis, and synaptogenesis after strokeAnnals of Neurology, 2003
- Rosuvastatin, a new HMG-CoA reductase inhibitor, upregulates endothelial nitric oxide synthase and protects from ischemic stroke in miceBrain Research, 2002
- Mevastatin, an HMG-CoA Reductase Inhibitor, Reduces Stroke Damage and Upregulates Endothelial Nitric Oxide Synthase in MiceStroke, 2001